Headquartered in Denmark, Novo Nordisk is the world leader in diabetes care. We offer the broadest diabetes product portfolio, including insulin, insulin injection devices & oral anti-diabetic drugs. We also have a leading position in areas such as haemostasis management, growth hormone therapy & HRT.
Mailing Address
Unit 923A-928, 9/F Trade Square 681, Cheung Sha Wan Rd Cheung Sha Wan
Hong Kong
Sign Out
